Protagenic Therapeutics, Inc. (PTIX)
NASDAQ: PTIX · Real-Time Price · USD
1.670
-0.010 (-0.60%)
At close: Dec 5, 2025, 4:00 PM EST
1.651
-0.019 (-1.15%)
After-hours: Dec 5, 2025, 6:19 PM EST
Protagenic Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -5.24 | -5.53 | -5 | -3.56 | -4.52 | -2.55 | |
| Depreciation & Amortization | 0.05 | 0.05 | 0.03 | 0 | - | 0 | |
| Other Amortization | - | - | 0.09 | 0.11 | 0.43 | 0.15 | |
| Loss (Gain) From Sale of Investments | -0.05 | -0.05 | 0.63 | 0.05 | 0 | - | |
| Stock-Based Compensation | 1 | 0.92 | 0.67 | 0.86 | 1.52 | 1.65 | |
| Other Operating Activities | -0.08 | -0.08 | - | - | -0.08 | -0.25 | |
| Change in Accounts Payable | 0.71 | 0.37 | -0.03 | -0.09 | 0.34 | -0.2 | |
| Change in Other Net Operating Assets | -0.01 | 0.1 | -0.09 | 0.63 | -0.48 | -0.16 | |
| Operating Cash Flow | -3.63 | -4.22 | -3.7 | -1.99 | -2.8 | -1.35 | |
| Capital Expenditures | - | - | -0.15 | -0 | - | - | |
| Investment in Securities | 1.6 | 2.8 | 4.93 | 1.6 | -9.91 | - | |
| Investing Cash Flow | 1.6 | 2.8 | 4.78 | 1.6 | -9.91 | - | |
| Short-Term Debt Issued | - | - | - | - | 0.1 | - | |
| Long-Term Debt Issued | - | - | - | - | - | 1.33 | |
| Total Debt Issued | - | - | - | - | 0.1 | 1.33 | |
| Short-Term Debt Repaid | - | - | - | - | -0.1 | - | |
| Total Debt Repaid | - | - | - | - | -0.1 | - | |
| Net Debt Issued (Repaid) | - | - | - | - | - | 1.33 | |
| Issuance of Common Stock | 2.07 | 1.96 | - | - | 12.58 | - | |
| Other Financing Activities | - | - | - | - | - | -0.1 | |
| Financing Cash Flow | 2.07 | 1.96 | - | - | 12.58 | 1.22 | |
| Foreign Exchange Rate Adjustments | 0 | 0 | 0 | 0.07 | 0 | -0 | |
| Net Cash Flow | 0.04 | 0.55 | 1.07 | -0.33 | -0.13 | -0.13 | |
| Free Cash Flow | -3.63 | -4.22 | -3.85 | -2 | -2.8 | -1.35 | |
| Free Cash Flow Per Share | -9.03 | -12.05 | -12.42 | -6.47 | -10.63 | -7.30 | |
| Levered Free Cash Flow | -1.71 | -2.2 | -2.47 | -0.73 | -1.29 | -0.65 | |
| Unlevered Free Cash Flow | -1.71 | -2.2 | -2.49 | -0.75 | -1.41 | -0.65 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.